Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Phase III-b, Multi-centre, Open-label, Parallel Study of Enoxaparin (Low Molecular Weight Heparin) Given Concomitantly With Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Gastric and Gastro-oesophageal Cancer

NCT00718354 is registered in ClinicalTrials.gov with Thrombosis Research Institute as lead sponsor.

NCT NCT00718354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00718354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Phase III-b, Multi-centre, Open-label, Parallel Study of Enoxaparin (Low Molecular Weight Heparin) Given Concomitantly With Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Gastric and Gastro-oesophageal Cancer
Lead sponsor
Thrombosis Research Institute
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2008
Completion date
August 31, 2010
Enrollment
740 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, gastroesophageal cancer